Addressable TV—which uses digital targeting and measurements for television advertisements—is changing the marketing landscape. It allows healthcare marketers to reach specific audiences with high precision, enhancing the effectiveness of advertising campaigns. During a panel discussion, industry […]
Philip Morris Introduces LEVIA: A Tobacco-Free Alternative for IQOS Device
Philip Morris International (PMI) has announced a new product for its IQOS 'heat-not-burn' device: a tobacco-free stick named LEVIA. The sticks use a 'non-tobacco substrate' infused with nicotine and come in various flavors. The tobacco company claims that LEVIA might not fall under the same tax […]
Galecto Laying Off 70% of Staff and Exploring Strategic Alternatives after Failed Lung Disease Drug Trial
Boston-based biotech firm Galecto plans to lay off 29 employees, approximately 70% of its workforce, after its lung disease drug candidate GB0139 failed in a phase IIb trial. Following the unsuccessful trial and predicted resource changes hinted at in mid-August, Galecto is now pursuing strategic […]
Higher Suicide Risk Among Health Care Workers, Especially Women: Study Reveals
A new study in the Journal of the American Medical Association suggests that health care workers, particularly registered nurses, health technicians and support workers, have a significantly higher risk of suicide than the general population. This is the first study to encompass all roles within the […]
UK’s Centre for Process Innovation Opens £26.4M RNA Centre of Excellence for Vaccine Production
The Centre for Process Innovation (CPI) in England has launched a £26.4 million ($32 million) plant named the RNA Centre of Excellence, which will facilitate the production of RNA products for early-stage clinical trials. The facility can potentially manufacture 100 million vaccines a year during […]
AstraZeneca and Daiichi Sankyo Plan Approval Filing for Breast Cancer Treatment Following Promising Trial Results
AstraZeneca and Daiichi Sankyo plan to seek approval for their breast cancer treatment datopotamab deruxtecan (Dato-DXd) following a clinical trial that revealed improved patient outcomes. The study included over 700 participants with inoperable or metastatic HR-positive, HER2-low, or negative […]
GA4GH Announces Ten New International Genomic Data Initiatives
The Global Alliance for Genomics and Health (GA4GH) has announced ten new international genomic data initiatives, bringing the total number of GA4GH Driver Projects to 28, involving 113 countries. These projects seek to implement GA4GH's genomic data standards in biomedical research and medicine and […]
The Illusions of the U.S. Pharmaceutical Industry: Misdirection in Drug Pricing, Innovation, and Regulation
The U.S. biopharmaceutical industry uses subtle illusion techniques similar to magicians to distract Americans from truths about drug pricing, innovation, and regulation. These illusions include the assumption that reducing drug prices would harm research and innovation, which in reality it […]
FDA Flags Manufacturing Shortfalls at Novo Nordisk’s North Carolina Plant, Impact on Drug Supply Uncertain
Novo Nordisk's shares have dropped after the FDA reported manufacturing deficiencies at the company's Clayton, North Carolina plant, which produces vital ingredient ingredients like semaglutide. From July 6 to 13, 2023, the FDA inspected the plant and criticized Novo for quality control lapses, […]
FDA Updates Guidelines on Using Single Clinical Investigation as Confirmatory Evidence for New Drug Approval
The FDA has issued a draft guide to clarify how evidence from a sole clinical investigation can be used as substantial evidence to approve new drugs. This draft guide is in continuation of guidance from 1998 and 2019 and specifies that the amount of confirmatory evidence required will depend on the […]
Biopharmaceutical Market Capitalization Rises in Q2 2023: Eli Lilly Takes the Lead
The market capitalization of the top 20 biopharmaceutical companies rose by 2.3% to $3.56tn in Q2 2023. Eli Lilly saw a 36.1% increase, making it the leading company in market capitalization, boosted by its diabetes drug Mounjaro and anticipated approval for its use in obesity treatment. […]
Alexion Pharmaceuticals Nears $125M Settlement in Class Action Lawsuit Over Alleged Unethical Sales Practices
A 2016 class action lawsuit against pharmaceutical company Alexion, which claimed that the company's unethical sales practices led to a decline in its stock price, might conclude after both parties proposed a $125 million settlement. The lawsuit represented shareholders who bought stocks between […]
Cognitive Ability Tied to COVID-19 Vaccination Rates
The study published in the Journal of Health Economics investigated a link between an individual's cognitive ability and their decision to receive the COVID-19 vaccination. The researchers found that people with higher cognitive abilities were likely to get vaccinated faster than those with lower […]
Swoop Launches AI Tool for Medication Adherence Predictive Targeting
Swoop, a prominent provider of custom audiences for the pharmaceutical and life sciences industry, has launched the Predictive AI Adherence Targeting. This innovative targeting methodology uses machine learning and artificial intelligence to predict which patients and healthcare providers (HCPs) are […]
AI-Enhanced Testing: Transforming the Landscape of Software Quality Assurance
Traditional test automation has limitations in replicating real-world user behavior and interactivity, which results in a need for an intelligent, dynamic approach to software testing. The leverage of AI in test automation presents a solution to this problem. AI-powered test automation faces […]
AstraZeneca Inks $42M Deal with Verge Genomics for AI-Driven Drug Discovery in Rare Neurodegenerative Diseases
Verge Genomics, an AI-drug discovery biotech company, has entered into a $42 million deal with AstraZeneca to discover new treatments for rare neurodegenerative diseases. Over four years, Verge will collaborate with AstraZeneca's rare disease division, Alexion, and is eligible for a further $840 […]
Medicare Price Negotiations for Drugs Begin in 2026: Eliquis Among Most Impacted
The Centers for Medicare & Medicaid Services (CMS) has disclosed a list of the initial ten drugs that will undergo Medicare price negotiations under the Inflation Reduction Act (IRA) starting from 2026, with the impact expected to be modest initially but gradually growing as more drugs are added […]
IPG Health Debuts Diversity Initiative for Clinical Trials
IPG Health announced a new clinical trial diversity offering aimed at ensuring equitable representation across various aspects of diversity, including race, gender, age, and other intersectional groups in clinical trials. This offering is part of its EDI+You strategy, which seeks to provide […]
Transitioning to a Learning Healthcare System: The Importance of High-Quality Data and Real-World Evidence
Healthcare systems typically rely on data from small-scale, costly trials to make decisions about patient care, but this approach can be slow and often insufficient. However, with the introduction of real-world evidence, which has become more credible due to the rise of AI, robust health data, and […]
Shortening Mental Health Treatment Waiting Times Could Save NHS Millions and Improve Patient Outcomes
What You Need to Know: Shortening treatment and waiting times for mental health conditions from 12 months to three could lead to financial savings for the NHS and improve treatment outcomes. The study, conducted by ieso Digital Health Ltd in partnership with Dorset HealthCare University NHS […]
Specialty Care Chief Bill Sibold Departs, New Executive Appointments Announced
Bill Sibold is leaving his role as specialty care chief at Sanofi after six years for an opportunity elsewhere. The company's current head of specialty care in North America, Brian Foard, will take on the role while a permanent successor is found. Before Sibold, David Meeker held the position. […]
Dive Deep Into the Biden Administration’s Drug Price Negotiations
The Biden administration has announced the selection of 10 high-cost prescription drugs for price negotiations with pharma companies to help older and disabled Americans afford their medication. The controversial move is a step towards addressing Medicare's drug pricing issue. President Biden hailed […]
Mallinckrodt Files for Second Bankruptcy; Plans $1 Billion Debt Reduction Amid Opioid Litigation
Drugmaker Mallinckrodt has filed for its second bankruptcy in the US within three years, with a restructuring plan aiming to alleviate $1 billion from its owed amount to victims of the opioid crisis. The firm began Chapter 11 proceedings following an agreement that would hand the company over to its […]
Danaher Acquires Life Sciences Supplier Abcam for $5.7 Billion
Danaher Corporation has announced the acquisition of Abcam, a UK-based life sciences supplier, for $5.7 billion. Abcam, a producer of research items such as antibodies and biomarkers, engaged in discussions with 20 other potential buyers before they decided to complete the acquisition with Danaher. […]
UK Economy Showing Signs of Growth Despite Skills Shortage and Employment Challenges in the Biosciences Industry
The UK economy appears to avoid a possible recession and even shows signs of growth, according to the latest data from the Office for National Statistics (ONS). However, concerns persist about a challenging employment scenario in the biosciences industry due to a digital and data skills shortage in […]
Cellares Secures $255M in Series C Round of Funding
Cellares, a cell therapy manufacturer based in South San Francisco, announced a $255 million series C investment round to finish constructing its commercial-scale cell therapy manufacturing facility in Bridgewater, NJ. Koch Disruptive Technologies led the funding round and included pharmaceutical […]
Leo Pharma Acquires Timber Pharmaceuticals for $36M to Bolster Dermatology Pipeline
Leo Pharma has agreed to acquire US-based Timber Pharmaceuticals, a clinical-stage biopharma company that develops treatments for rare skin conditions, for $36 million. The deal mandates an initial payment of $14 million and commits to $22 million in further payments as future milestones are […]
Target RWE to Showcase Innovative Epidemiology Research and Launch Syndicated Science™ Insights
Target RWE, a leader in real-world evidence, will present innovative research in epidemiology and statistics at the International Society for Pharmacoepidemiology's 39th annual meeting from August 23-27, 2023. The company's top executives will conduct a pre-conference skills course on 'Methods and […]
Advancements in Healthcare: The Influential Roles of Artificial Intelligence and Data Science
The last decade in healthcare has seen notable advancements due to artificial intelligence (AI), particularly data science. By using data-driven insights, healthcare decisions are more accurate and personalized. This article highlights five key healthcare data science projects: Google's […]
Preliminary Data Suggests Moderna’s Updated Covid-19 Vaccine Effective Against Expected Fall Variants
Moderna's preliminary data suggests that its updated COVID-19 vaccine can effectively combat expected variants this fall, including Eris and Fornax. This news comes amid a recent surge in COVID cases across the US. Moderna and Pfizer/BioNTech hope for FDA approval for their updated vaccines in time […]
